Study of Fazirsiran (TAK-999, ARO-AAT) in Patients With Alpha-1 Antitrypsin Deficiency Associated Liver Disease (AATD)
Clinical trial NCT03946449 · COMPLETED
Trial details
- NCT number
- NCT03946449
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-31
- Primary completion
- 2022-04-28
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.